S'abonner

An MDR Salmonella Enteritidis sublineage associated with gastroenteritis outbreaks and invasive disease in China - 05/03/25

Doi : 10.1016/j.jinf.2025.106421 
Xiaoyi Zheng a, b, Ying Xiang a, Xiaoying Li a, Xinying Du a, Yule Wang a, Sai Tian a, Jingzhuang Xue a, Ying Huang a, HONGBO LIU a, Qi Wang a, Hongbo Liu a, Hui Wang a, Chao Wang a, Mingjuan Yang a, Huiqun Jia a, Ligui Wang a, Xuebin Xu c, , Lihua Song b, , Hongbin Song a, , Shaofu Qiu a,
a Center for Disease Control and Prevention of Chinese PLA, Beijing, China 
b College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China 
c Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China 

Corresponding authors.

Summary

Objectives

Salmonella enterica serovar Enteritidis (S. Enteritidis) is a commonly reported pathogen which adapts to multiple hosts and causes critical disease burden at a global level. Here, we investigated a recently derived epidemic sublineage with multidrug resistance (MDR), which have caused extended time-period and cross-regional gastroenteritis outbreaks and even invasive nontyphoidal Salmonella disease (iNTS) in China.

Methods

Whole-genome sequencing and antimicrobial resistance (AMR) testing were applied to 729 Chinese S. Enteritidis isolates in relation to gastroenteritis outbreaks, gastrointestinal-sporadic and iNTS infections, spanning 28 years (1994–2021) in China. Phylogenomic analysis was performed to explore the population structure and evolutionary history of the Chinese isolates within a global context. Molecular investigations of AMR genes, virulence factors, mobile genetic elements and pan-genomes were also performed.

Results

The Chinese S. Enteritidis collections exhibited a high level of multidrug resistance (MDR), including high resistance to nalidixic acid (97.67%). Notably, the multidrug resistance rate of iNTS strains has significantly increased over the past decade. Phylogenomic analysis showed that the majority of the Chinese isolates (98.63%) were distributed in the global pandemic lineage L1, while the other lineages were highly continent-specific. Particularly, the Chinese isolates were predominantly distributed in sublineages L1.2 (37.45%) and L1.3 (59.26%), forming two main Chinese clades (MCC1&2). The most recent common ancestor of MCC1&2 dated back to 1944 and 2004, respectively. The lineage L1, especially MCC1&2, harbored the most amount of AMR determinants and virulence genes, which was mainly due to the presence of a hybrid virulence-resistance plasmid and coexistence of different types of AMR plasmids in S. Enteritidis.

Conclusions

S. Enteritidis has evolved unique clonal clusters, MCC1&2, with critical MDR in China, which phylogenetically constitute an extension of the globally epidemic lineage and were characterized by distinct genetic traits. These clades have induced extensive outbreaks of gastroenteritis and serious cases of iNTS in China, underscoring the pressing nature and severity of this public health crisis. Implementing the One-Health strategy, longstanding routine surveillance and further genomic epidemiological studies are urgently required to capture epidemics, monitor changes in bacterial populations and determine the consequent risk to global public health.

Le texte complet de cet article est disponible en PDF.

Highlights

WGS & AMR testing of 729 Chinese S. Enteritidis isolates in relation to gastrointestinal & invasive infections.
High rates of MDR in Chinese S. Enteritidis to nalidixic acid, ampicillin, tetracycline, etc.
Phylogeny of Six continent-specific lineages, MCC1&2 in the global lineage dominant in China.
Definition of ≤3 SNPs as the reference cutoff of genetic similarity among outbreak isolates.
MCC1&2 sublineages harboring most hybrid virulence-resistance plasmid & multiple AMR plasmids.

Le texte complet de cet article est disponible en PDF.

Keywords : Salmonella Enteritidis, Multidrug resistance, Genomics, Phylogenetic analysis, Gastroenteritis infection


Plan


© 2025  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 90 - N° 3

Article 106421- mars 2025 Retour au numéro
Article précédent Article précédent
  • Rezafungin in special populations with candidaemia and/or invasive candidiasis
  • Oliver A. Cornely, Hervé Dupont, Malgorzata Mikulska, Riina Rautemaa-Richardson, Carolina Garcia-Vidal, George R. Thompson, Martin Hoenigl
| Article suivant Article suivant
  • Risk of invasive meningococcal disease in people with sickle cell disease: A systematic review
  • Catherine Isitt, Helen Campbell, Catherine A. Cosgrove, Mary E. Ramsay, Paul T. Heath, Ray Borrow, Shamez N. Ladhani

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.